PL103783B1 - Sposob wytwarzania 5-m-toliloksyuracylu - Google Patents
Sposob wytwarzania 5-m-toliloksyuracylu Download PDFInfo
- Publication number
- PL103783B1 PL103783B1 PL1977199633A PL19963377A PL103783B1 PL 103783 B1 PL103783 B1 PL 103783B1 PL 1977199633 A PL1977199633 A PL 1977199633A PL 19963377 A PL19963377 A PL 19963377A PL 103783 B1 PL103783 B1 PL 103783B1
- Authority
- PL
- Poland
- Prior art keywords
- tolyloxy
- uracil
- compound
- ethyl
- methylphenoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/706,123 US4080454A (en) | 1976-07-16 | 1976-07-16 | 5-M-Tolyloxyuracil, anti-ulcer agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL199633A1 PL199633A1 (pl) | 1978-04-10 |
| PL103783B1 true PL103783B1 (pl) | 1979-07-31 |
Family
ID=24836300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1977199633A PL103783B1 (pl) | 1976-07-16 | 1977-07-14 | Sposob wytwarzania 5-m-toliloksyuracylu |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US4080454A (enExample) |
| JP (1) | JPS5337673A (enExample) |
| AR (1) | AR213652A1 (enExample) |
| AT (1) | AT351561B (enExample) |
| BE (1) | BE856710A (enExample) |
| CA (1) | CA1061788A (enExample) |
| CH (1) | CH622512A5 (enExample) |
| CS (1) | CS212264B2 (enExample) |
| DD (1) | DD131556A5 (enExample) |
| DE (1) | DE2731736A1 (enExample) |
| DK (1) | DK139029B (enExample) |
| EG (1) | EG12762A (enExample) |
| ES (1) | ES460686A1 (enExample) |
| FI (1) | FI772183A7 (enExample) |
| FR (1) | FR2358399A1 (enExample) |
| GB (1) | GB1542178A (enExample) |
| GR (1) | GR68686B (enExample) |
| HU (1) | HU177713B (enExample) |
| IL (1) | IL52409A (enExample) |
| LU (1) | LU77764A1 (enExample) |
| NL (1) | NL7707729A (enExample) |
| NO (1) | NO772489L (enExample) |
| PH (1) | PH13190A (enExample) |
| PL (1) | PL103783B1 (enExample) |
| PT (1) | PT66808B (enExample) |
| SE (1) | SE421125B (enExample) |
| SU (1) | SU673169A3 (enExample) |
| YU (1) | YU171677A (enExample) |
| ZA (1) | ZA773927B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55158095A (en) * | 1979-05-25 | 1980-12-09 | Zenkosha Tokei Kk | Controller for washing machine |
| KR101577554B1 (ko) | 2005-08-22 | 2015-12-14 | 멜리어 파마슈티칼스 아이, 인코포레이티드 | Ｌｙｎ 키나제 활성의 조절 및 관련된 장애의 치료를 위한 방법 및 제제 |
| AU2008218765A1 (en) * | 2007-02-20 | 2008-08-28 | Melior Pharmaceuticals I, Inc. | Methods of identifying activators of lyn kinase |
| EP2180894A4 (en) * | 2007-07-23 | 2012-08-29 | Melior Pharmaceuticals I Inc | METHOD OF ACTIVATING IRS-1 AND ACT |
| US8552184B2 (en) * | 2008-07-03 | 2013-10-08 | Melior Pharmaceuticals I, Inc. | Compounds and methods for treating disorders related to glucose metabolism |
| WO2011150300A1 (en) | 2010-05-28 | 2011-12-01 | Melior Pharmaceuticals I, Inc. | Prevention of pancreatic beta cell degeneration |
| EP3609500B1 (en) | 2017-04-10 | 2024-11-13 | Melior Pharmaceuticals I, Inc. | Treatment of adipocytes |
| EP3755334A4 (en) | 2018-02-21 | 2022-03-23 | Melior Pharmaceuticals I, Inc. | TREATMENT OF LIVER DISEASES |
-
1976
- 1976-07-16 US US05/706,123 patent/US4080454A/en not_active Expired - Lifetime
-
1977
- 1977-06-27 GR GR53819A patent/GR68686B/el unknown
- 1977-06-27 CA CA281,423A patent/CA1061788A/en not_active Expired
- 1977-06-28 SE SE7707471A patent/SE421125B/xx unknown
- 1977-06-28 IL IL52409A patent/IL52409A/xx unknown
- 1977-06-29 ZA ZA00773927A patent/ZA773927B/xx unknown
- 1977-07-05 PH PH19953A patent/PH13190A/en unknown
- 1977-07-11 FR FR7721285A patent/FR2358399A1/fr active Granted
- 1977-07-11 DE DE19772731736 patent/DE2731736A1/de not_active Withdrawn
- 1977-07-11 YU YU01716/77A patent/YU171677A/xx unknown
- 1977-07-11 BE BE1008274A patent/BE856710A/xx unknown
- 1977-07-12 NL NL7707729A patent/NL7707729A/xx not_active Application Discontinuation
- 1977-07-12 JP JP8349077A patent/JPS5337673A/ja active Granted
- 1977-07-13 CH CH870277A patent/CH622512A5/fr not_active IP Right Cessation
- 1977-07-13 ES ES460686A patent/ES460686A1/es not_active Expired
- 1977-07-13 SU SU772502606A patent/SU673169A3/ru active
- 1977-07-13 EG EG418/77A patent/EG12762A/xx active
- 1977-07-13 CS CS774680A patent/CS212264B2/cs unknown
- 1977-07-13 HU HU77PI583A patent/HU177713B/hu unknown
- 1977-07-13 DK DK318177AA patent/DK139029B/da unknown
- 1977-07-13 FI FI772183A patent/FI772183A7/fi not_active Application Discontinuation
- 1977-07-13 NO NO772489A patent/NO772489L/no unknown
- 1977-07-14 DD DD7700200058A patent/DD131556A5/xx unknown
- 1977-07-14 PL PL1977199633A patent/PL103783B1/pl unknown
- 1977-07-14 GB GB7729667A patent/GB1542178A/en not_active Expired
- 1977-07-14 LU LU77764A patent/LU77764A1/xx unknown
- 1977-07-14 AT AT509277A patent/AT351561B/de not_active IP Right Cessation
- 1977-07-14 AR AR268432A patent/AR213652A1/es active
- 1977-07-14 PT PT66808A patent/PT66808B/pt unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8552009B2 (en) | Substituted pyrimido 4.5-d pyrimidin-4-one compounds for modulating TRPV3 function | |
| US9486455B2 (en) | Compounds for modulating TRPV3 function | |
| PL146070B1 (en) | Method of obtaining 2-/n-substituted guanidin/4-/1,2,4-triazol-5-il/-thiazoles | |
| PL103783B1 (pl) | Sposob wytwarzania 5-m-toliloksyuracylu | |
| EP0774257B1 (en) | Use of piperazine and homopiperazine compounds for the inhibition of cellular adhesion and infiltration | |
| SK216092A3 (en) | Using of xantine derivatives for treating of secondary lesions of neurous cells and functional defects after injuring of cranium and cerebrum | |
| JP4814789B2 (ja) | ６−ヒドロキシベンズブロマロン又はその塩からなる医薬組成物 | |
| EP0087629A2 (en) | Antiinflammatory and/or analgesic 2,3-Diaryl-5-halo thiophenes | |
| US4361700A (en) | Pyridopyrimidinone derivatives | |
| NO170013B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive di-t-butylfenoler substituert med alkoxy- eller benzyloxygruppe eller en benzylthiogrupp | |
| CN107619428A (zh) | 鸟氨酸与门冬氨酸二肽化合物的酰化衍生物及其应用 | |
| NO136574B (enExample) | ||
| KR100373948B1 (ko) | 호산성과립구의병적인과반응성을감소시키기위한크산틴유도체를포함하는약제학적조성물,신규한크산틴화합물및이의제조방법 | |
| EP4119165A1 (en) | Novel 3,5-diaminobenzoic acid compound, and pin1 inhibitor and therapeutic agent for inflammatory diseases using same | |
| CN112457291B (zh) | 苯并硫代吡喃酮类化合物的盐及其制备方法和用途 | |
| IE55670B1 (en) | A pharmaceutical composition for topical application for treating atopic dermatitis | |
| EP0623623B1 (en) | 2-aminoethanesulfonic acid/zinc complex | |
| CA1252108A (en) | ( )-cyanidan-3-ol derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter | |
| US12545643B2 (en) | 3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same | |
| US4107172A (en) | Uricosuric diuretic composition | |
| KR100556559B1 (ko) | 2-(4-(4-(4,5-디클로로-2-메틸이미다졸-1-일)부틸)-1-피페라지닐)-5-플루오로피리미딘, 이것의 제조 방법 및 이것의치료적 용도 | |
| CN110452168A (zh) | N-苯基-n-喹啉羧酸类化合物及其制法和药物用途 | |
| JPH0827007A (ja) | 血糖降下剤 | |
| JPH0262554B2 (enExample) | ||
| GB2201343A (en) | Lowering blood uric acid levels |